Strides Pharma Science Limited (Strides) has successfully completed the inspection carried out by the World Health Organization (WHO) at its Puducherry facility between 16-20 January 2023. The Puducherry facility caters to the U.S., Other Regulated Markets, and Institutional businesses and can produce finished dosage formulation products across multiple dosage formats.
Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 328.55 as compared to the previous close of Rs. 327.85. The total number of shares traded during the day was 5753 in over 363 trades.
The stock hit an intraday high of Rs. 329.65 and intraday low of 325.60. The net turnover during the day was Rs. 1886666.00.